Evaluation of liaison-clinical pathway for patients with breast cancer undergoing adjuvant therapy after curative operation--data from questionnaire survey of 56 clinics and 105 patients
Ogawa, Y.; Aono, T.; Yamada, T.; Nishikawa, K.; Ikeda, K.; Tokunaga, S.; Okawa, K.; Ikehara, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(8): 1477-1481
2010
ISSN/ISBN: 0385-0684 PMID: 20716871 Document Number: 641870
To evaluate the liaison-clinical pathway for patients with breast cancer introduced since May 2008, the data from a questionnaires survey of 56 clinics and 105 patients were reviewed. Half of the clinics specialized in internal medicine. 93% of physicians recognized the utility of the pathway while 24% made the most of the pathway. About 40% of the clinics wished to enlarge both the patient number and treatment materials. Half of the patients were employed. 55% of patients valued the pathway as helpful. And 29% of patients used the patient booklet at all times. 8% of patients replied they had complaints went to clinics. There has been no serious problem in using the pathway. Countermeasures to electronic health records in clinics, and responses to requests from each patient will be needed.